Literature DB >> 20715086

Endoscopic-assisted versus curettage adenoidectomy: a prospective, randomized, double-blind study with objective outcome measures.

Murat Songu1, Canan Altay, Zehra Hilal Adibelli, Hamit Adibelli.   

Abstract

OBJECTIVE: To establish whether there is both objectively and subjectively improved recovery in children receiving endoscopic-assisted adenoidectomy, compared with children receiving curettage adenoidectomy. STUDY
DESIGN: Prospective, randomized, double-blinded study.
METHODS: Thirty-eight patients who underwent adenoidectomy alone or in combination with tonsillectomy before the planned tympanomastoid surgery with an age range from 8 to 12 years were enrolled in the study. Children were prospectively and randomly assigned into two groups: the endoscopic-assisted adenoidectomy and the curettage adenoidectomy. The main subjective parameters were the nasopharyngoscopy and the symptom improvement scale, whereas the main objective parameter was the midsagittal reformatted images of the temporal bone computerized tomographies of patients who underwent adenoidectomy before the planned tympanomastoid surgery. To adequately compare the utility of one technique versus the other, blood loss and operative time were also reviewed.
RESULTS: Evaluation of the temporal bone computerized tomographies of patients by adenoidal/nasopharyngeal ratios revealed a statistically significant difference with a mean ratio of 0.41 in the curettage and 0.30 in the endoscopic-assisted group. However, both groups had a significant improvement in the symptom improvement scale with no evidence for a significant difference between the endoscopic-assisted and curettage groups.
CONCLUSIONS: Although, objective outcomes reveal that endoscopic-assisted adenoidectomy technique was superior to curettage adenoidectomy in reducing adenoidal size after surgery, subjectively no differences were noted between two methods.

Entities:  

Mesh:

Year:  2010        PMID: 20715086     DOI: 10.1002/lary.21045

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Endoscopic nasopharyngeal exploration at the end of conventional curettage adenoidectomy.

Authors:  Mosaad Abdel-Aziz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-11       Impact factor: 2.503

2.  Plasma Dissection Versus Tissue Dissection in Adenoid Surgery.

Authors:  Vaidik Mayurkumar Chauhan; Kalpesh B Patel; Rajesh Vishwakarma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-07-29

3.  Combined Conventional and Endoscopic Microdebrider-Assisted Adenoidectomy: A Tertiary Centre Experience.

Authors:  Amal T Das; S B Prakash; V Priyadarshini
Journal:  J Clin Diagn Res       Date:  2017-02-01

4.  Paediatric adenoidectomy: endoscopic coblation technique compared to cold curettage.

Authors:  L Di Rienzo Businco; A M Angelone; A Mattei; L Ventura; M Lauriello
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-04       Impact factor: 2.124

5.  Endoscopic assisted adenoidectomy versus conventional curettage adenoidectomy: a meta-analysis of randomized controlled trials.

Authors:  Liyun Yang; Yamin Shan; Shili Wang; Changping Cai; Hao Zhang
Journal:  Springerplus       Date:  2016-04-11

6.  Endoscopic adenoidectomy: a systematic analysis of outcomes and complications in 1006 patients.

Authors:  Alberto Maria Saibene; Cecilia Rosso; Carlotta Pipolo; Paolo Lozza; Alberto Scotti; Filippo Ghelma; Fabiana Allevi; Alberto Maccari; Giovanni Felisati
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-02       Impact factor: 2.124

7.  Endoscopic Adenoidectomy in Children With Otitis Media With Effusion and Mild Hearing Loss.

Authors:  Pasquale Capaccio; Sara Torretta; Givlia Anna Marciante; Paola Marchisio; Stella Forti; Lorenzo Pignataro
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-03-07       Impact factor: 3.372

8.  Partial resection of hypertrophic torus tubarius for recurred snoring: Case series.

Authors:  Jeong-Whun Kim; Chae Seo Rhee; Hahn Jin Jung
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.